The company conducts research, manufacture, packaging, distribution and import of pharmaceutical products as well as registration, acquisition and disposal of related patents and the granting of licenses to third parties. Aspen Bad Oldesloe GmbH is a 100% subsidiary of Aspen Pharmacare Holdings Ltd., Durban, South Africa, and is domiciled in Bad Oldesloe (HR B 9561 HL). In the 2023/24 financial year the site generated revenues of €81.1m, of which €75.4m related to contract manufacturing, and produced 48.3 million packs. Revenues are earned mainly with the main customer Aspen Global Inc., Grand Bay/Mauritius, and two third-party customers, and the distribution area covers more than 130 countries.
Die Forschung, Herstellung, Verpackung, der Vertrieb und die Einfuhr von pharmazeutischen Erzeugnissen in verarbeitetem oder unverarbeitetem Zustand, sowie die Eintragung, der Erwerb und die Veräußerung entsprechender Patente, deren Auswertung und die Vergabe von Lizenzen an Dritte. Das Unternehmen führt die bisherigen arzneimittelrechtlich relevanten Tätigkeiten der GlaxoWellcome GmbH & Co. KG, Bad Oldesloe, fort.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Lübeck Local Court, HRB 9561 (as of 29 October 2026)
| Name | Type | City |
|---|---|---|
| Chris Botha | Geschäftsführer(in) | Balito/Südafrika |
| Lorraine Hill | Geschäftsführer(in) | Durban/Südafrika |
Source: German Commercial Register (Handelsregister) Lübeck Local Court, HRB 9561 (as of 29 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €81,149,703 | -€3,674,638 | €129,528,916 | 465 |
| 2023 | €72,166,779 | -€794,965 | €128,922,509 | 453 |
| 2022 | €66,585,062 | -€11,677,759 | €118,599,758 | 454 |
| 2021 | €68,783,091 | -€4,916,353 | €113,075,099 | 452 |
| 2020 | €65,409,631 | €604,885 | €106,543,716 | 431 |
| 2019 | €59,399,427 | €182,126 | €97,505,800 | 412 |
| 2018 | €60,317,657 | €324,792 | €96,693,432 | 400 |
| 2017 | €56,377,740 | €472,070 | €92,785,724 | 404 |
| 2016 | €50,910,796 | €226,735 | €92,649,275 | 404 |
| 2015 | €47,561,089 | €834,661 | €93,791,555 | 393 |
Sign in to download data
Source: German Commercial Register (Handelsregister) Lübeck Local Court, HRB 9561 (as of 29 October 2026)
PAION AG
Aachen · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Mundipharma Gesellschaft mit beschränkter Haftung
Frankfurt am Main · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
mibe GmbH Arzneimittel
Sandersdorf-Brehna · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €34,380,488 | 26.9% |
| Material Costs | €86,880,004 | 67.9% |
| Depreciation | €5,450,367 | 4.3% |
| Interest & Similar | €1,173,889 | 0.9% |
